Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Eduardo Imanol AgüeroUniversidad de Buenos Aires, Facultad de Medicina, Instituto de Oncología Ángel H. Roffo, Área de Investigación, Buenos Aires C1417DTB, Argentina.
Silvia María Gómez LópezUniversidad de Buenos Aires, Facultad de Medicina, Instituto de Oncología Ángel H. Roffo, Área de Investigación, Buenos Aires C1417DTB, Argentina.
Ana Belén Peñaherrera-PazmiñoCentro de Investigación Biomédica (CENBIO), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170527, Ecuador.ORCID 0000-0002-3886-7297
Matías TelladoVetOncologia-Clínica Oncológica Veterinaria, Buenos Aires C1408BGD, Argentina.
Maximiliano Sebastián PérezCentro IREN, Universidad Tecnológica Nacional (UTN), Buenos Aires B1706EAH, Argentina.
Betiana LernerCentro IREN, Universidad Tecnológica Nacional (UTN), Buenos Aires B1706EAH, Argentina.ORCID 0000-0003-3341-5686
Denise BelgoroskyUniversidad de Buenos Aires, Facultad de Medicina, Instituto de Oncología Ángel H. Roffo, Área de Investigación, Buenos Aires C1417DTB, Argentina.ORCID 0000-0002-7038-6442
Ana María EijánUniversidad de Buenos Aires, Facultad de Medicina, Instituto de Oncología Ángel H. Roffo, Área de Investigación, Buenos Aires C1417DTB, Argentina.
Funding
Agencia Nacional de Promoción Científica y Tecnológica PICT START-UP 2020-00017; PICT-2020-01571; PICT-2021-00058; PICT-2021-GRF-00464Biothera FoundationInstituto de Oncología Ángel H. Roffo, Universidad de Buenos Airesthe Mertelsmann Foundation gGmbHUBACyT 20720190100005BA
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
cancer stem cellschemotherapy responsemicrofluidic devicepersonalized oncologysphere formation assaysustainable development goal 3tumor-derived spheres
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Towards Personalized Medicine: Microdevice-Assisted Evaluation of Cancer Stem Cell Dynamics and Treatment Response. · full record | OpenQuestion